Epidemiological studies suggest a strong association between hypertension and ischemic
heart disease (IHD), and hypertension is a major independent risk factor for the …

Ischemic heart disease (IHD) affects about 16 million adults in the USA. Many more
individuals likely harbor subclinical coronary disease. Hypertension (HTN) continues to be a …

Hypertension is still the number one global killer. No matter what causes are, lowering blood
pressure can significantly reduce cardiovascular complications, cardiovascular death, and …

Patients with hypertension and concomitant cardiovascular (CVD) conditions are at high risk
for developing deleterious CVD-related clinical sequelae. The selection of therapeutic …

Pharmacological treatment of hypertension significantly reduces the incidence of
cardiovascular diseases. Unfortunately, only a fraction of hypertensive patients benefit …

Mild-to-moderate essential hypertension is the most common medical problem seen by
physicians in Western populations, and pharmacologic antihypertensive therapy is now …

Hypertension is the most prevalent and significant modifiable risk factor in individuals with
concomitant coronary artery disease. The number of individuals with hypertension is …

The management of the high-risk patient with hypertension has become more challenging in
recent years. Drug therapy should be initiated earlier and at lower blood pressure levels in …

In general, the treatment of hypertension is very rewarding: headache and symptoms of
heart failure are relieved, retinopathy regresses, hypertensive encephalopathy is prevented …

For most patients with systemic hypertension, long-term drug treatment is indicated and is
beneficial. There is overwhelming evidence to suggest that antihypertensive drugs offer …